Retatrutide appears to be a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating https://marleyfdzp441888.fitnell.com/77019607/retatrutide-a-promising-new-treatment-for-obesity